Praxis Bioresearch

Praxis Bioresearch is a biopharmaceutical company focused on discovering and developing treatments for chronic neuropsychiatric and neurodegenerative diseases. Praxis's primary development candidate is PRX-P4-003, a novel stimulant designed to deliver the proven clinical activity of currently marketed stimulants while reducing the risk of abuse and addiction.